Cargando…
Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice
BACKGROUND: Immunity to conserved viral antigens is an attractive approach to develop a universal vaccine against epidemic and pandemic influenza. A nucleoprotein (NP)-based vaccine has been explored and preliminary studies have shown promise. However, no study has explored the immunity and cross-pr...
Autores principales: | Huang, Baoying, Wang, Wenling, Li, Renqing, Wang, Xiuping, Jiang, Tao, Qi, Xiangrong, Gao, Yingying, Tan, Wenjie, Ruan, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547759/ https://www.ncbi.nlm.nih.gov/pubmed/23272943 http://dx.doi.org/10.1186/1743-422X-9-322 |
Ejemplares similares
-
Robust Immunity and Heterologous Protection against Influenza in Mice Elicited by a Novel Recombinant NP-M2e Fusion Protein Expressed in E. coli
por: Wang, Wenling, et al.
Publicado: (2012) -
Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats
por: Wang, Wenling, et al.
Publicado: (2019) -
Generation of an Attenuated Tiantan Vaccinia Virus Strain by Deletion of Multiple Genes
por: Li, Yiquan, et al.
Publicado: (2017) -
Optimisation of Prime–Boost Immunization in Mice Using Novel Protein-Based and Recombinant Vaccinia (Tiantan)-Based HBV Vaccine
por: Chen, Hong, et al.
Publicado: (2012) -
Immunization of mice with vaccinia virus Tiantan strain yields antibodies cross-reactive with protective antigens of monkeypox virus
por: Yang, Lei, et al.
Publicado: (2022)